Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
- Author
- ROUGIER, P; BUGAT, R; BONNETERRE, J; ADENIS, A; SEITZ, J. F; GANEM, G; NAMER, M; CONROY, T; NEGRIER, S; MERROUCHE, Y; BURKI, F; MOUSSEAU, M; DOUILLARD, J. Y; HERAIT, P; MAHJOUBI, M; CULINE, S; SUC, E; BRUNET, P; BECOUARN, Y; YCHOU, M; MARTY, M; EXTRA, J. M
Bellon-Rhône-Poulenc Rorer, Neuilly sur Seine, France
Centre Alexis Vautrin, Vandoeuvre Les Nancy, France
Centre Antoine Lacassagne, Nice, France
Centre Claudius Regaud, Toulouse, France
Centre Hospitalier Universitaire de Grenoble, La Tronche, France
Centre Jean Bernard, Le Mans, France
Centre Léon Bérard, Lyon, France
Centre Oscar Lambret, Lille, France
Centre Rend Gauducheau, Saint Herblain, France
Centre Val d'Aurelle, Montpellier, France
Clinique du Château, Toulouse, France
Fondation Bergonié, Bordeaux, France
Hôpital Saint Louis, Paris, France
Institut Gustave Roussy, Villejuif, France
Institut Paoli Calmettes, Marseille, France - Source
Journal of clinical oncology. 1997, Vol 15, Num 1, pp 251-260 ; ref : 36 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Carcinome Chimiothérapie Côlon Essai clinique phase II Fluoropyrimidine dérivé Fluorouracil Homme Irinotécan Métastase Prétraitement Rectum Stade avancé Traitement Pyrano indolizino quinoléine dérivé Appareil digestif pathologie Côlon pathologie Intestin pathologie Rectum pathologie Tumeur maligne
- Keyword (en)
- Antineoplastic agent Carcinoma Chemotherapy Colon Phase II trial Fluoropyrimidine derivatives Fluorouracil Human Irinotecan Metastasis Pretreatment Rectum Advanced stage Treatment Digestive diseases Colonic disease Intestinal disease Rectal disease Malignant tumor
- Keyword (es)
- Anticanceroso Carcinoma Quimioterapia Colón Ensayo clínico fase II Fluoropirimidina derivado Fluorouracilo Hombre Irinotecán Metástasis Pretratamiento Recto Estadio avanzado Tratamiento Aparato digestivo patología Colón patología Intestino patología Recto patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2585566
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.1997.15.1.251 
https://dx.doi.org/10.1200/JCO.1997.15.1.251
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1200\/JCO.1997.15.1.251\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"251\";s:8:\"\u0000*\u0000epage\";s:3:\"260\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ROUGIER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:8:\"BUGAT, R\";i:1;s:13:\"BONNETERRE, J\";i:2;s:9:\"ADENIS, A\";i:3;s:11:\"SEITZ, J. F\";i:4;s:8:\"GANEM, G\";i:5;s:8:\"NAMER, M\";i:6;s:9:\"CONROY, T\";i:7;s:10:\"NEGRIER, S\";i:8;s:12:\"MERROUCHE, Y\";i:9;s:8:\"BURKI, F\";i:10;s:11:\"MOUSSEAU, M\";i:11;s:15:\"DOUILLARD, J. Y\";i:12;s:9:\"HERAIT, P\";i:13;s:11:\"MAHJOUBI, M\";i:14;s:9:\"CULINE, S\";i:15;s:6:\"SUC, E\";i:16;s:9:\"BRUNET, P\";i:17;s:11:\"BECOUARN, Y\";i:18;s:8:\"YCHOU, M\";i:19;s:8:\"MARTY, M\";i:20;s:11:\"EXTRA, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1200\/JCO.1997.15.1.251\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"251\";s:8:\"\u0000*\u0000epage\";s:3:\"260\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ROUGIER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:8:\"BUGAT, R\";i:1;s:13:\"BONNETERRE, J\";i:2;s:9:\"ADENIS, A\";i:3;s:11:\"SEITZ, J. F\";i:4;s:8:\"GANEM, G\";i:5;s:8:\"NAMER, M\";i:6;s:9:\"CONROY, T\";i:7;s:10:\"NEGRIER, S\";i:8;s:12:\"MERROUCHE, Y\";i:9;s:8:\"BURKI, F\";i:10;s:11:\"MOUSSEAU, M\";i:11;s:15:\"DOUILLARD, J. Y\";i:12;s:9:\"HERAIT, P\";i:13;s:11:\"MAHJOUBI, M\";i:14;s:9:\"CULINE, S\";i:15;s:6:\"SUC, E\";i:16;s:9:\"BRUNET, P\";i:17;s:11:\"BECOUARN, Y\";i:18;s:8:\"YCHOU, M\";i:19;s:8:\"MARTY, M\";i:20;s:11:\"EXTRA, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1200\/JCO.1997.15.1.251\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1200\/JCO.1997.15.1.251\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"251\";s:8:\"\u0000*\u0000epage\";s:3:\"260\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ROUGIER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:8:\"BUGAT, R\";i:1;s:13:\"BONNETERRE, J\";i:2;s:9:\"ADENIS, A\";i:3;s:11:\"SEITZ, J. F\";i:4;s:8:\"GANEM, G\";i:5;s:8:\"NAMER, M\";i:6;s:9:\"CONROY, T\";i:7;s:10:\"NEGRIER, S\";i:8;s:12:\"MERROUCHE, Y\";i:9;s:8:\"BURKI, F\";i:10;s:11:\"MOUSSEAU, M\";i:11;s:15:\"DOUILLARD, J. Y\";i:12;s:9:\"HERAIT, P\";i:13;s:11:\"MAHJOUBI, M\";i:14;s:9:\"CULINE, S\";i:15;s:6:\"SUC, E\";i:16;s:9:\"BRUNET, P\";i:17;s:11:\"BECOUARN, Y\";i:18;s:8:\"YCHOU, M\";i:19;s:8:\"MARTY, M\";i:20;s:11:\"EXTRA, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1200\/JCO.1997.15.1.251\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"251\";s:8:\"\u0000*\u0000epage\";s:3:\"260\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ROUGIER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:8:\"BUGAT, R\";i:1;s:13:\"BONNETERRE, J\";i:2;s:9:\"ADENIS, A\";i:3;s:11:\"SEITZ, J. F\";i:4;s:8:\"GANEM, G\";i:5;s:8:\"NAMER, M\";i:6;s:9:\"CONROY, T\";i:7;s:10:\"NEGRIER, S\";i:8;s:12:\"MERROUCHE, Y\";i:9;s:8:\"BURKI, F\";i:10;s:11:\"MOUSSEAU, M\";i:11;s:15:\"DOUILLARD, J. Y\";i:12;s:9:\"HERAIT, P\";i:13;s:11:\"MAHJOUBI, M\";i:14;s:9:\"CULINE, S\";i:15;s:6:\"SUC, E\";i:16;s:9:\"BRUNET, P\";i:17;s:11:\"BECOUARN, Y\";i:18;s:8:\"YCHOU, M\";i:19;s:8:\"MARTY, M\";i:20;s:11:\"EXTRA, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1200\/JCO.1997.15.1.251\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"251\";s:8:\"\u0000*\u0000epage\";s:3:\"260\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ROUGIER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:8:\"BUGAT, R\";i:1;s:13:\"BONNETERRE, J\";i:2;s:9:\"ADENIS, A\";i:3;s:11:\"SEITZ, J. F\";i:4;s:8:\"GANEM, G\";i:5;s:8:\"NAMER, M\";i:6;s:9:\"CONROY, T\";i:7;s:10:\"NEGRIER, S\";i:8;s:12:\"MERROUCHE, Y\";i:9;s:8:\"BURKI, F\";i:10;s:11:\"MOUSSEAU, M\";i:11;s:15:\"DOUILLARD, J. Y\";i:12;s:9:\"HERAIT, P\";i:13;s:11:\"MAHJOUBI, M\";i:14;s:9:\"CULINE, S\";i:15;s:6:\"SUC, E\";i:16;s:9:\"BRUNET, P\";i:17;s:11:\"BECOUARN, Y\";i:18;s:8:\"YCHOU, M\";i:19;s:8:\"MARTY, M\";i:20;s:11:\"EXTRA, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:167:\"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
